Patterns of Correlation of Plasma Ceruloplasmin in Sepsis

Journal of Surgical Research

Volumn 144, Issue 1, 2008, Pages 107-110

  Chiarla, Carlo ^a   Giovannini, Ivo ^a,b   Siegel, John H ^c  

^a CNR   (Italy)

^b Surgical Intensive Care   (Italy)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

acidosis; acute phase proteins; amino acids; cyst(e)ine; cystathionine; liver dysfunction; plasma ceruloplasmin; plasma triglycerides; sepsis; taurine

Indexed keywords

ACUTE PHASE PROTEIN; ALKALINE PHOSPHATASE; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; CYSTATHIONE; CYSTEINE; TAURINE; TRIACYLGLYCEROL; TYROSINE; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; AMINO ACID ANALYSIS; ARTICLE; BILIRUBIN BLOOD LEVEL; CERULOPLASMIN BLOOD LEVEL; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEPATOBILIARY DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER DYSFUNCTION; MALE; METABOLIC ACIDOSIS; PH MEASUREMENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEPSIS;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; AMINO ACIDS; BILIRUBIN; C-REACTIVE PROTEIN; CERULOPLASMIN; FEMALE; HUMANS; MALE; REGRESSION ANALYSIS; SEPSIS; TRIGLYCERIDES;

EID: 36849044743     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.03.024     Document Type: Article

References (47)

1. Kingston I.B., Kingston B.L., and Putnam F.W. Complete amino acid sequence of a histidine-rich proteolytic fragment of human ceruloplasmin. Proc Natl Acad Sci USA 76 (1979) 1668
2. Ryden L., and Norder H. Covalent chromatography as a means of isolating thiol peptides from large proteins: Application to human ceruloplasmin. J Chromatogr 215 (1981) 341
3. Cha M.K., and Kim I.H. Ceruloplasmin has a distinct active site for the catalyzing glutathione-dependent reduction of alkyl hydroperoxide. Biochemistry 38 (1999) 12104
4. Zaitsev V.N., Zaitseva I., Papiz M., et al. An X-ray crystallographic study of the binding sites of the azide inhibitor and organic substrates to ceruloplasmin, a multicopper oxidase in the plasma. J Biol Inorg Chem 4 (1999) 579
5. Sengupta S., Wehbe C., Majors A.K., et al. Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation. J Biol Chem 276 (2001) 46896
6. Bielli P., and Calabrese L. Structure to function relationships in ceruloplasmin: A "moonlighting" protein. Cell Mol Life Sci 59 (2002) 1413
7. Giurgea N., Constantinescu M.I., Stanciu R., et al. Ceruloplasmin-acute-phase reactant or endogenous antioxidant?. The case of cardiovascular disease. Med Sci Monit 11 (2005) RA48
8. Twomey P.J., Viljoen A., House I.M., et al. Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice. Clin Chem 51 (2005) 1558
9. Ehrenwald E., and Fox P.L. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J Clin Invest 97 (1996) 884
10. Cappelli-Bigazzi M., Ambrosio G., Musci G., et al. Ceruloplasmin impairs endothelium-dependent relaxation of rabbit aorta. Am J Physiol (Heart Circ Physiol 42) 273 (1997) H2843
11. Fox P.L., Mazumder B., Ehrenwald E., et al. Ceruloplasmin and cardiovascular disease. Free Rad Biol Med 28 (2000) 1735
12. Uriu-Adams J.Y., and Keen C.L. Copper, oxidative stress, and human health. Mol Aspect Med 26 (2005) 268
13. Shukla N., Maher J., Masters J., et al. Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?. Atherosclerosis 187 (2006) 238 (Epub Jan 9, 2006)
14. Awadallah S.M., Hamad M., Jbarah I., et al. Autoantibodies against oxidized LDL correlate with serum concentrations of ceruloplasmin in patients with cardiovascular disease. Clin Chim Acta 365 (2006) 330
15. Aiginger P., Kolarz G., and Willvonseder R. Copper in ankylosing spondylitis and rheumatoid arthritis. Scand J Rheumatol 7 (1978) 75
16. Prasad A.S., Brewer G.J., Schoomaker E.B., et al. Hypocupremia induced by zinc therapy in adults. JAMA 240 (1978) 2166
17. Gitlin J.D. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J Biol Chem 263 (1988) 6281
18. Hoffman II H.N., Phyliky R.L., and Fleming C.R. Zinc-induced copper deficiency. Gastroenterology 94 (1988) 508
19. Liukko P., Erkkola R., and Bergink E.W. Progestagen-dependent effect on some plasma proteins during oral contraception. Gynecol Obstet Invest 25 (1988) 118
20. Menkes J.H. Kinky hair disease: Twenty-five years later. Brain Dev 10 (1988) 77
21. Song S., Chen J.K., He M.L., et al. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin. Contraception 39 (1989) 385
22. Mainero A., Cruz C., and Pedraza-Chaverri J. Serum and urinary ceruloplasmin in experimental nephrotic syndrome. Clin Invest Med 15 (1992) 295
23. Cunningham J., Leffell M., Mearkle P., et al. Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: Evidence for increased oxidative stress as a variable complication. Metabolism 44 (1995) 996
24. Jones R.J., Lewis S.J., Smith J.M., et al. Undetectable serum ceruloplasmin in a woman with chronic hepatitis C infection. J Hepatol 32 (2000) 703
25. Hellman N.E., and Gitlin J.D. Ceruloplasmin metabolism and function. Annu Rev Nutr 22 (2002) 439
26. Nayak S.B., Bhat V.R., Upadhyay D., et al. Copper and ceruloplasmin status in serum of prostate and colon cancer patients. Indian J Physiol Pharmacol 47 (2003) 108
27. Kumagi T., Horiike N., Michitaka K., et al. Recent clinical features of Wilson's disease with hepatic presentation. J Gastroenterol 39 (2004) 1165
28. Le Lan C., Ropert M., Laine F., et al. Serum ceruloplasmin and ferroxidase activity are not decreased in hepatic failure related to alcoholic cirrhosis: Clinical and pathophysiological implications. Alcohol Clin Exp Res 28 (2004) 775
29. Panichi V., Taccola D., Manca Rizza G., et al. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients. J Nephrol 17 (2004) 715
30. Alebic-Juretic A., and Frkovic A. Plasma copper concentrations in pathological pregnancies. J Trace Elem Med Biol 19 (2005) 191
31. Nayak S.B., Yashwanth S., Pinto S.M., et al. Serum copper, ceruloplasmin, protein thiols, and thiobarbituric acid reactive substance status in liver cancer associated with elevated levels of α-fetoprotein. Indian J Physiol Pharmacol 49 (2005) 341
32. Doustjalali S.R., Yusof R., Govindasamy G.K., et al. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J Med Invest 53 (2006) 20
33. Greenspan L., McLellan B.A., and Greig H. Abbreviated injury scale and injury severity score: A scoring chart. J Trauma 25 (1985) 60
34. Stevens L.E. Gauging the severity of surgical sepsis. Arch Surg 118 (1983) 1190
35. Skau T. Severity of illness in intra-abdominal infection. A comparison of two indexes. Arch Surg 120 (1985) 152
36. Seber G.A.F. Linear regression analysis (1977), Wiley, New York, NY 369
37. Vincent J.L., Moreno R., Takala J., et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 22 (1996) 707
38. Cerra F.B., Siegel J.H., Coleman B., et al. Septic autocannibalism. A failure of exogenous nutritional support. Ann Surg 192 (1980) 570
39. Siegel J.H., Cerra F.B., Coleman B., et al. Physiologic and metabolic correlations in human sepsis. Surgery 86 (1979) 163
40. Giovannini I., Chiarla C., Giuliante F., et al. Hypocholesterolemia in surgical trauma, sepsis, other acute conditions, and critical illness. In: Kramer M.A. (Ed). Trends in Cholesterol Research (2005), Nova Science Publisher, Hauppauge, NY 137
41. Kroll M.H., and Elin R.J. Interference with clinical laboratory analyses. Clin Chem 40 (1994) 1996
42. Bornhorst J.A., Roberts R.F., and Roberts W.L. Assay-specific differences in lipemic interference in native and intralipid-supplemented samples. Clin Chem 50 (2004) 2197
43. Kaviarasan K., Arjunan M.M., and Pugalendi K.V. Lipid profile, oxidant-antioxidant status, and glycoprotein components in hyperlipidemic patients with/without diabetes. Clin Chim Acta 362 (2005) 49
44. Memisogullari R., and Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. J Diabetes Complications 18 (2004) 193
45. Gutteridge J.M., Quinlan G.J., Mumby S., et al. Primary plasma antioxidants in adult respiratory distress syndrome patients: Changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins. J Lab Clin Med 124 (1994) 263
46. Pathirana C., and Grimble R.F. Taurine and serine supplementation modulates the metabolic response to tumor necrosis factor α in rats fed a low protein diet. J Nutr 122 (1992) 1369
47. Grimble R.F. Nutritional antioxidants and the modulation of inflammation: Theory and practice. New Horizons 2 (1994) 175